Latest filing published 21 May 2024 for Dexcom Inc.
Barbara Kahn sits on the board of Dexcom Inc, the only issuer in a record of 71 filings published from 2016 to 2024. 48 are sales, worth EUR 9.1 million in total with a median of EUR 156,508. The largest are EUR 665,909 on January 14, 2019, EUR 644,186 on June 10, 2020 and EUR 490,019 on August 8, 2016. No purchase appears; the record also counts 14 other filings and 9 grants.
Three years concentrate the activity: 2019 and 2022 with 18 filings each, and 2020 with 16. The other years hold from 2 to 6. Nothing falls in the last twelve months, the latest filing having been published May 21, 2024. Publication takes a median of 4 days.
Within 30 days of colleagues at Dexcom Inc, Kahn has 47, 45 and 32 own market trades, in that order, all in the same direction. Names in order: Steven Robert Pacelli, Kevin R. Sayer and Richard Doubleday.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 81 declarations